| 摘要 |
The invention discloses the therapeutic potential of 3,4-dihydroxy-3',5'-dimethoxy-trans-stilbene (3-hydroxypterostilbene or 3-HPT) in colon cancer and prostate cancer. The present invention discloses the therapeutic potential of 3-HPT in the management of colon and prostate cancers. More specifically, the present invention discloses the apoptotic and autophagy properties exhibited by 3-HPT in controlling tumorigenesis in the colon and prostate glands. The present invention also discloses the unexpected anti-tumor effects of 3- HPT over pterostilbene in colon cancer and prostate cancer models. |
